The systematic erythalamus (SLE) is a complex self-immuno-disease that can stretch through multiple organs and systems, posing a serious threat to the health of patients. In the SLE treatment programme, the injection of C-ball protein is a mentioned treatment, so can it be effective in treating systemic red weeds?
Protein C is an immunoglobin G (IgG) antibodies extracted from healthy human plasma. It contains antiviral, bacterial and toxin-resistant antibodies and is widely clinically used for the treatment of multiple diseases. For systemic erythalamus, the treatment role is mainly reflected in the following aspects.
First, the protein is immune. SLE patients are over-active in their immune system, with their own antibodies creating and attacking their own tissues. Protein C can regulate the activity of immune cells by combining it with receptors on the surface of multiple immunocytes, such as inhibiting B lymphocytes to produce their own antibodies and reducing the formation of immune compounds, thus mitigating attacks on their own tissue by the immune system. For example, in the case of SLE patients with severe self-immunization responses, such as large amounts of protein urine and reduced platelets, C-ball proteins can rapidly regulate the immune balance and mitigate these symptoms.
Second, the C-ball protein can seal off the Fc receptor of the single-nucleus cell system. During the SLE outbreak, the immune complex activates the single nucleus system, further exacerbating the inflammatory response. C-ball proteins help to protect the function of organs by reducing the intensity of the inflammation response by blocking Fc receptors and preventing the combination of immunocomposed compounds with single nucleus cells. For example, in the case of lupus nephritis, the reduction of local renal inflammation can slow down progress to some extent.
However, injecting C-protein is not a systematic root treatment of red weeds. It is only a supplementary treatment and is used mainly in the following specific situations. The first is that when SLE patients are suffering from acute stress periods and have a poor response to conventional sugar cortex hormones and immunosuppressants, C-ball protein can be used as a quick and effective complementary treatment to help patients through difficult times. For example, when a patient suffers from severe neuropsychophages, such as convulsions, comas, or serious damage to the blood system, such as severe anaemia, particle cell deficiency, the C-ball protein can work quickly to improve the patient ‘ s symptoms and buy time for subsequent treatment.
Second, for specific groups, such as SLE patients during pregnancy, the relative safety of the C-ball protein makes it an optional treatment for fear of the effects of certain drugs on the foetus and is able to minimize adverse effects on the foetus while controlling maternal conditions.
But what needs to be noted is that injected C-ball protein is not without risk. There may be adverse reactions, such as allergies such as fever, headaches, rashes and, in a few cases, the spread of blood-borne diseases (although this risk is very low under formal blood product management). Moreover, proteomics of C are relatively expensive and long-term or large-scale use can place a significant financial burden on patients.
In conclusion, the specific role and application of injecting C-ball protein in the systematic treatment of erythropopae is that it can be used as an effective assistive treatment to help control conditions and alleviate symptoms, but not as a substitute for conventional sugar cortex hormones and immunosuppressants. In clinical practice, doctors develop the most appropriate treatment for patients on the basis of a combination of the patient ‘ s specific condition, physical condition and financial circumstances, taking into account the advantages and disadvantages, in order to improve the treatment and quality of life of persons with systemic red lupus.
